Differential desensitization of thromboxane A2 receptor subtypes

Circulation Research

Volumn 80, Issue 4, 1997, Pages 551-556

  Yukawa, Masao ^a   Yokota, Ryoji ^a   Eberhardt, Robert T ^a   Von Andrian, Laila ^a   Ware, J Anthony ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

desensitization; downregulation; eicosanoid; prostaglandin; protein kinase C

Indexed keywords

CALCIUM ION; CALPHOSTIN C; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; PHORBOL ESTER; PROTEIN KINASE C; THROMBOXANE A2 RECEPTOR; THROMBOXANE A2 RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0030912002     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.4.551     Document Type: Article

References (36)

1. 2. Fed Proc. 1987;46:133-138.
2. 2 receptors. Biochem Pharmacol. 1991;42:537-544.
3. 2 stimulates vascular smooth muscle hypertrophy by upregulating the synthesis and release of endogenous basic fibroblast growth factor. J Biol Chem. 1993;268:17397-17403.
4. 2 receptors on human endothelial cells. Circ Res. 1993;72:958-965.
5. Clesham G, Parsaee H, Joseph S, McEwan JR, MacDermot J. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF. Cardiovasc Res. 1992;26:513-517.
6. 2 receptor. Nature. 1991;349:617-620.
7. 2 receptor isoforms in human platelets. J Clin Invest. 1996;97:949-956.
8. 2 receptor. J Biol Chem. 1994;269:19256-19261.
9. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 1993;365:166-170.
10. Negishi M, Sugimoto Y, Irie A, Narumiya S, Ichikawa A. Two isoforms of prostaglandin E receptor EP3 subtype: different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J Biol Chem. 1993;268:9517-9521.
11. Dorn GW. Regulation of response to thromboxane A2 in CHRF-288 megakaryocytic cells. Am J Physiol. 1992;262:C991-C999.
12. Dorn GW, Davis MG. Differential megakaryocytic desensitization to platelet agonists. Am J Physiol. 1992;263:C864-C872.
13. 2 receptor by the mimetic U46619. J Pharmacol Exp Ther. 1988;247:1133-1138.
14. Murray R, FitzGerald GA. Regulation of thromboxane receptor activation in human platelets. Proc Natl Acad Sci U S A. 1989;86:124-128.
15. Okwu AK, Ullian ME, Halushka PV. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptor. J Pharmacol Exp Ther. 1992;92:238-245.
16. Dorn GW, Becker MW. Growth factors downregulate vascular smooth muscle thromboxane receptors independent of cell growth. Am J Physiol. 1992;262:C927-C933.
17. 2 receptor. J Biol Chem. 1994;269:29914-29919.
18. Lohse MJ, Andexinger S, Pitcher J, Trukawinski S, Codina J, Fuare JP, Caron MG, Lefkowitz RJ. Receptor-specific desensitization with purified proteins: kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta-adrenergic receptor and rhodopsin systems. J Biol Chem. 1992;267:8558-8564.
19. Grabarek J, Raychowdhury M, Ravid K, Kent KC, Newman PJ, Ware JA. Identification and functional characterization of protein kinase C isoenzymes in platelets and HEL cells. J Biol Chem. 1992;267:10011-10017.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
21. 2 receptors in human platelets. J Pharmacol Exp Ther. 1988;245:786-792.
22. Chang JD, Xu Y, Raychowdhury MK, Ware JA. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein Kinase C (nPKC). J Biol Chem. 1993;268:14208-14214.
23. Gatti A, Wang X, Robbinson PJ. Protein kinase C-alpha is multiply phosphorylated in response to phorbol ester stimulation of PC12 cells. Biochim Biophys Acta. 1996;1313:111-118.
24. Pears C, Stabel S, Cazaubon S, Parker PJ. Studies on the phosphorylation of protein kinase C-alpha. Biochem J. 1992;283;515-518.
25. Kent KC, Mii S. Harrington EO, Chang JD, Mallette S, Ware JA. Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation. Circ Res. 1995;77:231-238.
26. 2+-independent isoforms of protein kinase C differentially translocate in smooth muscle. Am J Physiol. 1992;263:C714-C719.
27. Eldar H, Zisman Y, Ullrich A, Livneh E. Overexpression of protein kinase C alpha-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J Biol Chem. 1990;265:13290-33296.
28. Harrington EO, Ware JA. Diversity of the protein kinase C gene family: implications for cardiovascular disease. Trends Cardiovasc Med. 1995;5:193-199.
29. Bouvier M, Hausdorff WP, DeBlasi A, O'Dowd BF, Kobilka BK, Caron MG, Lefkowitz RJ. Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature. 1988;333:370-373.
30. Habib A, Shen YM, Creminon C, Maclouf J, FitzGerald GA. Post translational modifications of thromboxane receptor isoforms. J Invest Med. 1996;44:263A. Abstract.
31. 1 in control of thrombin receptor-phospholipase C coupling in human platelets. J Biol Chem. 1988;263:3363-3371.
32. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983-989.
33. Meagher EA, FitzGerald GA. Disordered eicosanoid formation in pregnancy-induced hypertension. Circulation. 1993;88:1324-1333.
34. 2 receptor in patients with acute myocardial infarction. Circulation. 1990;81:212-218.
35. 2 receptors in patients with pregnancy induced hypertension. Thromb Res. 1993;70:205-210.
36. 2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci U S A. 1989;86:7585-7589.